Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex  Yury Herasimenka, Paola Cescutti, Giuseppe Impallomeni,

Slides:



Advertisements
Similar presentations
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Advertisements

Rapid emergence of a ceftazidime-resistant Burkholderia multivorans strain in a Cystic Fibrosis patient  Joshua R. Stokell, Raad Z. Gharaibeh, Todd R.
Treatment compliance in children and adults with Cystic Fibrosis
Exopolysaccharides produced by Burkholderia cenocepacia recA lineages IIIA and IIIB  Luigi Chiarini, Paola Cescutti, Laura Drigo, Giuseppe Impallomeni,
Megan W. France, Mary E. Dodd, John R. Govan, Catherine J. Doherty, A
Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center 
P. Whitaker, N. Shaw, J. Gooi, C. Etherington, S. Conway, D. Peckham 
CFTR mutation in an Arab patient: Clinical and functional features of 875+1G→A/875+1G→A genotype  Elide Spinelli, Manuela Seia, Paola Melotti, Eleonora.
Heleen Van Acker, Elisabeth Van Snick, Hans J. Nelis, Tom Coenye 
R. Roberts, L. Speight, J. Lee, L. George, R. I. Ketchell, D. Lau, J
PCR detection of Burkholderia cepacia complex as one of key factors to handle a long- term outbreak  Klara Dedeckova, Libor Fila, Veronika Skalicka, Jana.
Novel diagnostic PCR assay for Burkholderia cenocepacia epidemic strain ST32 and its utility in monitoring infection in cystic fibrosis patients  Klara.
How does heart rate recovery after sub-maximal exercise correlate with maximal exercise testing in children with CF?  Sarah P. Cohen, David M. Orenstein 
Avani C. Modi, Crystal S. Lim, Nami Yu, David Geller, Mary H
Single high-dose oral vitamin D3 (stoss) therapy — A solution to vitamin D deficiency in children with cystic fibrosis?  Darren Shepherd, Yvonne Belessis,
Megan R. Nelson, Craig R. Adamski, Audrey Tluczek 
Successful treatment of cepacia syndrome
Urinary incontinence in 9���16��year olds with cystic fibrosis compared to other respiratory conditions and a normal group  W.J. Browne, C.J. Wood, M.
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Genomovar status, virulence markers and genotyping of Burkholderia cepacia complex strains isolated from Brazilian cystic fibrosis patients  Kátia Maia.
Microbiological yield from induced sputum compared to oropharyngeal swab in young children with cystic fibrosis  Marco Zampoli, Komala Pillay, Henri Carrara,
Cirrhosis and other liver disease in cystic fibrosis
The ease of breathing test tracks clinical changes in cystic fibrosis
Controlled clinical trials in cystic fibrosis — are we doing better?
Anju Anand, Elizabeth Tullis, Anne Stephenson, Preyanka Abhyankar 
D. Stevens, P.J. Oades, N. Armstrong, C.A. Williams 
Claire J. Tipping, Rebecca L. Scholes, Narelle S. Cox 
Cystic fibrosis mortality trend in Italy from 1970 to 2011
Long-term daily high and low doses of azithromycin in children with cystic fibrosis: A randomized controlled trial  S.K. Kabra, R. Pawaiya, Rakesh Lodha,
Amyloidosis in cystic fibrosis: A case series
Spontaneous coronary artery dissection associated with coughing
A.H. Gifford  Journal of Cystic Fibrosis 
Inhalation solutions — Which ones may be mixed
Physiologic endpoints for clinical studies for cystic fibrosis
Antonia V. Bennett, Donald L. Patrick, James F. Lymp, Todd C
Characterisation of mutations and genotype–phenotype correlation in cystic fibrosis: Experience from India  Shivaram S. Shastri, Madhulika Kabra, Sushil.
Sophia L. Markantonis, Anna Katelari, Eleni Pappa, Stavros Doudounakis 
E. Tschiedel, H. Grasemann, F. Ratjen  Journal of Cystic Fibrosis 
Colon Cancer in Cystic Fibrosis patients: Is this a growing problem?
Transient isolation of Burkholderia multivorans and Burkholderia cenocepacia from a Brazilian cystic fibrosis patient chronically colonized with Burkholderia.
Anastasios Lekkas, Khin M. Gyi, Margaret E. Hodson 
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis  Christopher R. Sudfeld, Elliott C. Dasenbrook, William.
Cytokine gene polymorphisms and severity of CF lung disease
Nasal polyposis in lung transplant recipients with cystic fibrosis
Narelle S. Cox, Jennifer Follett, Karen O. McKay 
Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis  Geraint B. Rogers, Lucas R. Hoffman,
Paternity in men with cystic fibrosis: a retrospective survey in France  Ingrid Duguépéroux, Dominique Hubert, Stéphane Dominique, Gil Bellis, Marc De.
Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic  Amanda L. Griffiths, Danielle F. Wurzel,
Gender differences in treatment adherence among youth with cystic fibrosis: Development of a new questionnaire  Joän M. Patterson, Melanie Wall, Jerica.
Trends in pathogens colonising the respiratory tract of adult patients with cystic fibrosis, 1985–2005  F.A. Millar, N.J. Simmonds, M.E. Hodson  Journal.
F. Vermeulen, P. Lebecque, K. De Boeck, T. Leal 
Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis  M.N. Hurley, A.H. Amin Ariff, C. Bertenshaw,
Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids  Francis J. Gilchrist, A.
V. Thompson, N. Mayer-Hamblett, M. Kloster, D. Bilton, P.A. Flume 
H. White, A.M. Morton, S.P. Conway, D.G. Peckham 
J.E. Spahr, R.B. Love, M. Francois, K. Radford, K.C. Meyer 
Daniel J. Smith, Gregory J. Anderson, Scott C. Bell, David W. Reid 
D.F. Waterhouse, A.M. McLaughlin, C.G. Gallagher 
CFTR modulators and pregnancy: Our work has only just begun
‘Peeling paint’ dermatitis as a presenting sign of cystic fibrosis
L. Nshimyumukiza, A. Bois, P. Daigneault, L. Lands, A. -M. Laberge, D
Cheryl Cameron, Mark W. Lodes, William M. Gershan 
Lutz Goldbeck, Sven Zerrer, Tim G. Schmitz  Journal of Cystic Fibrosis 
Khin M. Gyi, Margaret E. Hodson, Magdi Y. Yacoub 
David Adeboyeku, Sandra Scott, Margaret E. Hodson 
Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)—A cause for concern? 
Elisabeth P. Dellon, Margaret W. Leigh, James R. Yankaskas, Terry L
Anne K. Swisher, Kathryn Moffett, Linda Baer 
Improved early diagnosis of Pseudomonas aeruginosa by real-time PCR to prevent chronic colonisation in a paediatric cystic fibrosis population  Elaine.
Respiratory physicians and clinic coordinators' attitudes to population-based cystic fibrosis carrier screening  Fiona Cunningham, Sharon Lewis, Lisette.
Presentation transcript:

Exopolysaccharides produced by clinical strains belonging to the Burkholderia cepacia complex  Yury Herasimenka, Paola Cescutti, Giuseppe Impallomeni, Silvia Campana, Giovanni Taccetti, Novella Ravenni, Flavio Zanetti, Roberto Rizzo  Journal of Cystic Fibrosis  Volume 6, Issue 2, Pages 145-152 (April 2007) DOI: 10.1016/j.jcf.2006.06.004 Copyright © 2006 European Cystic Fibrosis Society Terms and Conditions

Fig. 1 Chemical structures of the EPS produced by Bcc. Journal of Cystic Fibrosis 2007 6, 145-152DOI: (10.1016/j.jcf.2006.06.004) Copyright © 2006 European Cystic Fibrosis Society Terms and Conditions

Fig. 2 1H and 13C NMR spectra of the sample BFI6 recorded at 50 °C (a and b), and 1H NMR spectrum of the polysaccharide cepacian recorded at 80 °C (c). The principal regions of the spectrum are shown. Journal of Cystic Fibrosis 2007 6, 145-152DOI: (10.1016/j.jcf.2006.06.004) Copyright © 2006 European Cystic Fibrosis Society Terms and Conditions

Fig. 3 Partial anomeric regions of the 1H NMR spectra of the de-acetylated exopolysaccharides BFI11, BFI4, and BFI8. Journal of Cystic Fibrosis 2007 6, 145-152DOI: (10.1016/j.jcf.2006.06.004) Copyright © 2006 European Cystic Fibrosis Society Terms and Conditions

Fig. 4 Partial anomeric regions of the 1H NMR spectra of the de-acetylated exopolysaccharides BFI9, BFI12, and C1576. Journal of Cystic Fibrosis 2007 6, 145-152DOI: (10.1016/j.jcf.2006.06.004) Copyright © 2006 European Cystic Fibrosis Society Terms and Conditions